Defining treatment success in rosacea as 'clear' may provide multiple patient benefits: results of a pooled analysis.

about

Human Skin Permeation Studies with PPARγ Agonist to Improve Its Permeability and Efficacy in Inflammatory Processes.

P2860

Q47248982-64081155-9AF7-4BEE-9879-223302ADB171

P2860

Defining treatment success in rosacea as 'clear' may provide multiple patient benefits: results of a pooled analysis.

Item

http://www.wikidata.org/entity/Q47558329

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Defining treatment success in ...... results of a pooled analysis.

@en

Defining treatment success in ...... results of a pooled analysis.

@nl

type

Item

label

Defining treatment success in ...... results of a pooled analysis.

@en

Defining treatment success in ...... results of a pooled analysis.

@nl

prefLabel

Defining treatment success in ...... results of a pooled analysis.

@en

Defining treatment success in ...... results of a pooled analysis.

@nl

P1476

Defining treatment success in ...... results of a pooled analysis.

@en

P2093

Gregor Schäfer

http://www.w3.org/2001/XMLSchema#string

Guy Webster

http://www.w3.org/2001/XMLSchema#string

J Mark Jackson

http://www.w3.org/2001/XMLSchema#string

Jerry Tan

http://www.w3.org/2001/XMLSchema#string

Martin Schaller

http://www.w3.org/2001/XMLSchema#string

Nabil Kerrouche

http://www.w3.org/2001/XMLSchema#string

P2860

Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments

Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation

Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data.

Measurement of health status. Ascertaining the minimal clinically important difference.

New insights into rosacea pathophysiology: a review of recent findings.

Interventions for Rosacea.

Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study.

Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group.

Emerging therapies in rosacea.

The psychological impact of rosacea and the influence of current management options.

P304

469-474

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09546634.2017.1343435

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28617145

http://www.w3.org/2001/XMLSchema#string

Defining treatment success in rosacea as 'clear' may provide multiple patient benefits: results of a pooled analysis.

about

P2860

P2860

Defining treatment success in rosacea as 'clear' may provide multiple patient benefits: results of a pooled analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698